D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 5.49M 5.49M 7.47M 9.77M 6.31M
Total Other Revenue -- -- -- -- --
Total Revenue 5.49M 5.49M 7.47M 9.77M 6.31M
Cost of Revenue -- -- -- -- --
Gross Profit 5.49M 5.49M 7.47M 9.77M 6.31M
SG&A Expenses 43.76M 38.94M 35.39M 33.87M 31.66M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 169.93M 162.08M 140.03M 120.27M 108.44M
Operating Income -164.44M -156.59M -132.56M -110.50M -102.13M
Income Before Tax -156.03M -149.63M -129.88M -109.00M -99.93M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -156.03 -149.63 -129.88 -109.00 -99.93
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -156.03M -149.63M -129.88M -109.00M -99.93M
EBIT -164.44M -156.59M -132.56M -110.50M -102.13M
EBITDA -163.30M -155.42M -131.41M -109.35M -100.98M
EPS Basic -0.42 -0.41 -0.38 -0.34 -0.33
Normalized Basic EPS -0.26 -0.25 -0.22 -0.20 -0.20
EPS Diluted -0.42 -0.41 -0.38 -0.34 -0.33
Normalized Diluted EPS -0.26 -0.25 -0.22 -0.20 -0.20
Average Basic Shares Outstanding 1.50B 1.45B 1.38B 1.28B 1.19B
Average Diluted Shares Outstanding 1.50B 1.45B 1.38B 1.28B 1.19B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --